Cargando…
EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Cystic Fibrosis Society.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192145/ http://dx.doi.org/10.1016/S1569-1993(21)01001-8 |
| _version_ | 1783705996289376256 |
|---|---|
| author | Hatziagorou, E. Peftoulidou, P. Toulia, I. Tasika, E. Chrysochoou, E.-A. Tsanakas, J. |
| author_facet | Hatziagorou, E. Peftoulidou, P. Toulia, I. Tasika, E. Chrysochoou, E.-A. Tsanakas, J. |
| author_sort | Hatziagorou, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8192145 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Cystic Fibrosis Society. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81921452021-06-11 EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis Hatziagorou, E. Peftoulidou, P. Toulia, I. Tasika, E. Chrysochoou, E.-A. Tsanakas, J. J Cyst Fibros ePoster Sessions European Cystic Fibrosis Society. 2021 2021-06-11 /pmc/articles/PMC8192145/ http://dx.doi.org/10.1016/S1569-1993(21)01001-8 Text en Copyright © 2021 European Cystic Fibrosis Society. All rights reserved. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | ePoster Sessions Hatziagorou, E. Peftoulidou, P. Toulia, I. Tasika, E. Chrysochoou, E.-A. Tsanakas, J. EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title | EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title_full | EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title_fullStr | EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title_full_unstemmed | EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title_short | EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| title_sort | eps1.03 recommended shielding against covid-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis |
| topic | ePoster Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192145/ http://dx.doi.org/10.1016/S1569-1993(21)01001-8 |
| work_keys_str_mv | AT hatziagoroue eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis AT peftoulidoup eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis AT touliai eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis AT tasikae eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis AT chrysochoouea eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis AT tsanakasj eps103recommendedshieldingagainstcovid19impactsphysicalactivitylevelsandadherencetoairwayclearancetherapyinpatientswithcysticfibrosis |